Literature DB >> 24719471

Dynamics of the antibody response to Plasmodium falciparum infection in African children.

Michael T White1, Jamie T Griffin1, Onome Akpogheneta2, David J Conway2, Kwadwo A Koram3, Eleanor M Riley4, Azra C Ghani1.   

Abstract

BACKGROUND: Acquired immune responses to malaria have widely been perceived to be short-lived, with previously immune individuals losing immunity when they move from malaria-endemic areas. However long-lived Plasmodium falciparum-specific antibody responses lasting for an individual's lifetime are frequently observed.
METHODS: We fit mathematical models of the dynamics of antibody titers to P. falciparum antigens from longitudinal cohort studies of African children to estimate the half-lives of circulating immunoglobulin G (IgG) antibodies and IgG antibody-secreting cells (ASCs).
RESULTS: Comparison of antibody responses in the younger Ghanaian cohort and the older Gambian cohort suggests that young children are less able to generate the long-lived ASCs necessary to maintain the circulating antibodies that may provide protection against reinfection. Antibody responses in African children can be described by a model 15 including both short-lived ASCs (half-life range, 2-10 days), which are responsible for boosting antibody titers following infection, and long-lived ASCs (half-life range, 3-9 years), which are responsible for maintaining sustained humoral responses.
CONCLUSIONS: The rapid decay of antibodies following exposure to malaria and the maintenance of sustained antibody responses can be explained in terms of populations of short-lived and long-lived ASCs.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Plasmodium falciparum; antibody; immunity; malaria; model

Mesh:

Substances:

Year:  2014        PMID: 24719471     DOI: 10.1093/infdis/jiu219

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  71 in total

1.  Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.

Authors:  Antje Blank; Kristin Fürle; Anja Jäschke; Michael Lanzer; Walter E Haefeli; Hermann Bujard; Gerd Mikus; Monika Lehmann; Johannes Hüsing; Kirsten Heiss; Thomas Giese; Darrick Carter; Ernst Böhnlein
Journal:  NPJ Vaccines       Date:  2020-01-31       Impact factor: 7.344

2.  Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Authors:  Xin-Xing Gu; Stanley A Plotkin; Kathryn M Edwards; Alessandro Sette; Kingston H G Mills; Ofer Levy; Andrea J Sant; Annie Mo; William Alexander; Kristina T Lu; Christopher E Taylor
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

3.  Anti-MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon.

Authors:  Angel Rosas-Aguirre; Kailash P Patra; Maritza Calderón; Katherine Torres; Dionicia Gamboa; Edith Arocutipa; Edith Málaga; Katherine Garro; Carlos Fernández; Grace Trompeter; Yossef Alnasser; Alejandro Llanos-Cuentas; Robert H Gilman; Joseph M Vinetz
Journal:  JCI Insight       Date:  2020-01-16

4.  Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity.

Authors:  Natalie M Bowman; Jonathan J Juliano; Cynthia J Snider; Oksana Kharabora; Steven R Meshnick; John Vulule; Chandy C John; Ann M Moormann
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

5.  Development and validation of serological markers for detecting recent Plasmodium vivax infection.

Authors:  Rhea J Longley; Michael T White; Eizo Takashima; Jessica Brewster; Masayuki Morita; Matthias Harbers; Thomas Obadia; Leanne J Robinson; Fumie Matsuura; Zoe S J Liu; Connie S N Li-Wai-Suen; Wai-Hong Tham; Julie Healer; Christele Huon; Chetan E Chitnis; Wang Nguitragool; Wuelton Monteiro; Carla Proietti; Denise L Doolan; Andre M Siqueira; Xavier C Ding; Iveth J Gonzalez; James Kazura; Marcus Lacerda; Jetsumon Sattabongkot; Takafumi Tsuboi; Ivo Mueller
Journal:  Nat Med       Date:  2020-05-11       Impact factor: 53.440

6.  Antibody dynamics in children with first or repeat Plasmodium falciparum infections.

Authors:  Eric Rogier; Doug Nace; Pedro R Dimbu; Brian Wakeman; James G Beeson; Chris Drakeley; Kevin Tetteh; Mateusz Plucinski
Journal:  Front Med (Lausanne)       Date:  2022-07-19

7.  Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.

Authors:  Cleopatra K Mugyenyi; Salenna R Elliott; Xi Zen Yap; Gaoqian Feng; Philippe Boeuf; Gregory Fegan; Faith F H Osier; Freya J I Fowkes; Marion Avril; Thomas N Williams; Kevin Marsh; James G Beeson
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 5.226

8.  Anopheles Salivary Biomarker as a Proxy for Estimating Plasmodium falciparum Malaria Exposure on the Thailand-Myanmar Border.

Authors:  Phubeth Ya-Umphan; Dominique Cerqueira; Gilles Cottrell; Daniel M Parker; Freya J I Fowkes; Francois Nosten; Vincent Corbel
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

9.  Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.

Authors:  Lilian Rose Pratt-Riccio; Daiana De Souza Perce-Da-Silva; Josué Da Costa Lima-Junior; Evelyn Kety Pratt Riccio; Marcelo Ribeiro-Alves; Fátima Santos; Mercia Arruda; Daniel Camus; Pierre Druilhe; Joseli Oliveira-Ferreira; Cláudio Tadeu Daniel-Ribeiro; Dalma Maria Banic
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

Review 10.  Humoral immune responses to infection: common mechanisms and unique strategies to combat pathogen immune evasion tactics.

Authors:  Ismail Sebina; Marion Pepper
Journal:  Curr Opin Immunol       Date:  2018-02-23       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.